Abstract:Objective To explore new treatment for airway inflammation in the future, through the determination of the influence of aldose reductase inhibitors on expression of cytokine and NF-κB in human bronchial epithelial cells after the stimulus of house dust mites. Methods Human bronchial epithelial cells were divided into three groups: blank (group A), 300 ng/ml HDM (group B), 300 ng/ml HDM+aldose reductase inhibitors Zopo (group C) and aldose reductase inhibitors Zopol (group D). The relative expression of NF-kappa B/p65mRNA, NF-kappa B/ p65 nuclear protein and protein of IL-29 and IL-6 in cell supernatant were assayed. Results The data showed that after 24 hours of combined action of house dust mites and aldose reductase inhibitors, the NF-kappa B/p65 mRNA level, NF-kappa B/p65 nuclear protein level, IL-6 protein level and IL-29 protein level of human bronchial epithelial cells in group C were significantly lower than those of group B (P < 0.05), but higher than group A (P < 0.05). There were no significant differences between group D and group A (P > 0.05). Conclusions Aldose reductase inhibitor zopolrestat regulates inflammatory signaling mediated by NF-kappa B. The expression of inflammatory factor in human bronchial epithelial cells significantly reduces because of zopolrestat.